Blood Glucose Awareness Training for Parents
Parent-Child Co-Regulation of Pediatric Diabetes, Phase 2
1 other identifier
interventional
77
1 country
2
Brief Summary
The purpose of this study is to test a training program for parents of children with T1DM.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Apr 2006
Typical duration for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2006
CompletedFirst Submitted
Initial submission to the registry
April 18, 2006
CompletedFirst Posted
Study publicly available on registry
April 19, 2006
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2008
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2008
CompletedJanuary 16, 2013
January 1, 2013
2.7 years
April 18, 2006
January 14, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Accuracy of blood glucose level estimation
Parents and children asked to report symptoms and give an estimated bg level. Later compared to actual bg levels to give an accuracy rating.
70 trials over a one month period
Study Arms (2)
BGAT Intervention
EXPERIMENTALBlood Glucose Awareness Training for Parents
Control
NO INTERVENTIONEnter PDA data and complete questionnaires only. No intervention received.
Interventions
Eligibility Criteria
You may qualify if:
- Parent/Guardian with primary responsibility for a child's diabetes management
- Child with T1DM between the ages 6 - 11 years.
- Duration of child's diabetes \> 1 year
- Routine self-testing of child's BG \> 2x day
- Intention to remain in the study's geographical region for the next 5 months
- Have a computer at home
You may not qualify if:
- Significant comorbidity in the child that could interfere with BG awareness or psychosocial status
- Medications taken by the child that interfere with symptom perception
- Psychiatric disorder in a parent or child
- Cognitive deficits/learning disabilities in the child that might preclude ability to complete the study protocol.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Virginialead
- Joslin Diabetes Centercollaborator
Study Sites (2)
Joslin Diabetes Center
Boston, Massachusetts, United States
University of Virginia
Charlottesville, Virginia, 22908, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Linda Gonder-Frederick, Ph.D.
University of Virginia, Department of Psychiatric Medicine, Behavioral Medicine Research
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Intervention Model
- FACTORIAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 18, 2006
First Posted
April 19, 2006
Study Start
April 1, 2006
Primary Completion
December 1, 2008
Study Completion
December 1, 2008
Last Updated
January 16, 2013
Record last verified: 2013-01